Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

The University of British Columbia

$37,000.00

Curbing the Emergence of Clonal Drift in Stem Cell Expansion Culture

FY 2023-24

Summary
Literature and Recent Progress As evolution guided the development of multicellular organisms, single cells adapted their social interactions to co-operate with one another. Nevertheless, remnants of natural selection remain - cells with higher fitness eliminate their relatively weak neighbours. Cell competition has been shown to play a significant role in the growth and repair of tissues, impacting organism survival as a whole. Cancer cells are an example of super-competitors, overtaking communal resources and out-competing the body's normal cells. Much as cancer cells emerge as "cheaters" within our tissues, cell populations grown outside the body are often overtaken by abnormal cells that acquire genetic mutations, giving them a fitness advantage. The emergence of abnormally fit cells continues to plague bioprocesses that aim to derive appropriate and relevant quantities of stem cells and their derivatives for downstream applications. Pluripotent stem cells (PSCs) are particularly powerful given their ability to indefinitely expand (make copies of themselves) and differentiate into all cell types in the body. However, owing to their great expansion potential, PSCs are particularly susceptible to mutations. Objectives and Methodology My long-term objective is to use cell competition as a new lens to reverse-engineer multicellular systems, uncovering how the rules that govern interactions between single cells lead to the success or peril of the whole population. My lab will serve as an interdisciplinary hub, providing mentorship to convergent researchers. By leveraging expertise in computational modeling, stem cells, and synthetic biology, we will design a novel pipeline to better maintain the quality and safety of PSC batches. There are two short-term objectives. First, we will apply a synthetic biology approach to develop a cellular "barcoding" platform to tag PSCs and their progeny with unique DNA identifiers, allowing us to manipulate them based on their barcode. Second, we will track the growth dynamics of each PSC as it expands. By applying a mathematical modeling strategy, we will predict the emergence of PSCs with abnormal fitness and use the active barcode to trigger a suicide switch in these cells, recovering the integrity of the cell batch. HQP I intend to train a diverse group of HQP, including 2 graduate and 5 undergraduate trainees. I will be conscious of using equitable and inclusive recruitment and mentoring practices. Impact The recent boom in the cell therapy sector, including the launch of the Centre for Commercialization of Regenerative Medicine and BlueRock Therapeutics in Canada, have increased the need to produce large quantities of cells. This work addresses a major challenge in the cell manufacturing pipeline, with a novel quality control strategy to maintain cell integrity. Our findings will be broadly applicable to bioprocesses, including protein, virus, and biopharmaceutical production.
Program
Discovery Grants Program - Individual
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2020-04198
Name nom
Shakiba, Nika
Department département
School of Biomedical Engineering
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2020
Award amount
37000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Biomedical technology
Research subject en
Génie biomédical
Research subject fr
Technologie biomédicale
Application title
Curbing the Emergence of Clonal Drift in Stem Cell Expansion Culture
Keyword
Bioprocess; Cell manufacturing; Clonal dynamics; DNA barcoding; DNA sequencing; Expansion culture; Mathematical modeling; Pluripotent stem cells; Stem cells; Synthetic biology
Application summary
Literature and Recent Progress As evolution guided the development of multicellular organisms, single cells adapted their social interactions to co-operate with one another. Nevertheless, remnants of natural selection remain - cells with higher fitness eliminate their relatively weak neighbours. Cell competition has been shown to play a significant role in the growth and repair of tissues, impacting organism survival as a whole. Cancer cells are an example of super-competitors, overtaking communal resources and out-competing the body's normal cells. Much as cancer cells emerge as "cheaters" within our tissues, cell populations grown outside the body are often overtaken by abnormal cells that acquire genetic mutations, giving them a fitness advantage. The emergence of abnormally fit cells continues to plague bioprocesses that aim to derive appropriate and relevant quantities of stem cells and their derivatives for downstream applications. Pluripotent stem cells (PSCs) are particularly powerful given their ability to indefinitely expand (make copies of themselves) and differentiate into all cell types in the body. However, owing to their great expansion potential, PSCs are particularly susceptible to mutations. Objectives and Methodology My long-term objective is to use cell competition as a new lens to reverse-engineer multicellular systems, uncovering how the rules that govern interactions between single cells lead to the success or peril of the whole population. My lab will serve as an interdisciplinary hub, providing mentorship to convergent researchers. By leveraging expertise in computational modeling, stem cells, and synthetic biology, we will design a novel pipeline to better maintain the quality and safety of PSC batches. There are two short-term objectives. First, we will apply a synthetic biology approach to develop a cellular "barcoding" platform to tag PSCs and their progeny with unique DNA identifiers, allowing us to manipulate them based on their barcode. Second, we will track the growth dynamics of each PSC as it expands. By applying a mathematical modeling strategy, we will predict the emergence of PSCs with abnormal fitness and use the active barcode to trigger a suicide switch in these cells, recovering the integrity of the cell batch. HQP I intend to train a diverse group of HQP, including 2 graduate and 5 undergraduate trainees. I will be conscious of using equitable and inclusive recruitment and mentoring practices. Impact The recent boom in the cell therapy sector, including the launch of the Centre for Commercialization of Regenerative Medicine and BlueRock Therapeutics in Canada, have increased the need to produce large quantities of cells. This work addresses a major challenge in the cell manufacturing pipeline, with a novel quality control strategy to maintain cell integrity. Our findings will be broadly applicable to bioprocesses, including protein, virus, and biopharmaceutical production.
The University of British Columbia - $37,000 Grant (2… | Canada Spends